Medpace Holdings, Inc. — Director's Dealing 2021

Jun 16, 2021

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Medpace Holdings, Inc. (MEDP)
CIK: 0001668397
Period of Report: 2021-06-14

Reporting Person: BURWIG SUSAN E (Exec. VP, Operations)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2021-06-14	Common Stock	M	7400	$23	Acquired	77405	Direct
2021-06-14	Common Stock	S	7400	$179.016	Disposed	70005	Direct
2021-06-14	Common Stock	M	7600	$28.32	Acquired	77605	Direct
2021-06-14	Common Stock	S	7600	$178.901	Disposed	70005	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2021-06-14	Employee Stock Option (Right to Buy)	$23	M	7400	Disposed	2023-08-10	Common Stock (7400)	Direct
2021-06-14	Employee Stock Option (Right to Buy)	$28.32	M	7600	Disposed	2024-03-15	Common Stock (7600)	Direct

Footnotes

F1: The sales reported on this Form 4 were effected pursuant to a limit order by the Reporting Person.

F2: The reported price is a weighted average price. These shares were sold in multiple transactions ranging from $178.50 to $179.33. The Reporting Person undertakes to provide full pricing information to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission upon request.

F3: The reported price is a weighted average price. These shares were sold in multiple transactions ranging from $178.43 to $179.51. The Reporting Person undertakes to provide full pricing information to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission upon request.

F4: Each option vested on August 10, 2020.

F5: Each option vested on March 15, 2021.